PATH AI Signal Analysis

PATH [bullish, medium confidence]: Consistent 4Q EPS beats (15.5% last quarter) and clean forensic accounting (100/100) indicate strong operational execution. Analyst price target of $15 (37.2% upside) suggests undervaluation despite mixed ratings (3B/18H/1S). No meaningful insider buying/selling activity detected (0 shares transacted) with zero-dollar sell transaction by CEO, suggesting data anomaly or non-actionable event. PATH faces regulatory headwinds in healthcare reimbursement (Medicare payment cuts) and energy compliance costs (emissions/coal waste rules). The April 14 Medicare payment system changes and April 13 coal combustion regulations directly increase operational costs with limited near-term mitigants. Bullish flow dominates with $2.5M net bullish sweeps in 48h, but high IV30D (89.5%) and 85th percentile volatility suggest overbought conditions. ATM put mispricing (67.